The Uganda AIDS Commission has announced a groundbreaking development in HIV prevention.
Research has shown that the six-monthly injection Lenacapavir offers 100% protection to HIV-negative individuals against acquiring HIV.
Uganda was one of the countries where scientists participated in carrying out this research.
Following the US Food and Drug Administration’s approval of its production and use, Lenacapavir will be made available in Uganda after close consultations with stakeholders and compliance with minimum requirements.
The Ministry of Health, working with relevant stakeholders, will undertake several steps to integrate Lenacapavir into Uganda’s HIV prevention program.
These steps include evaluating and licensing the drug for use in the country.
The national HIV prevention guidelines will also be updated.
Additionally, healthcare providers will be trained on the use of Lenacapavir.
The drug will also be incorporated into the essential drugs list.
Tools will be revised to capture data on its use.
Once these steps are completed, Lenacapavir will expand options for individuals at high risk of HIV infection.
In the meantime, oral PrEP will continue to be offered at designated facilities.
Uganda remains committed to providing effective and innovative solutions to end AIDS as a public health threat by 2030.
The country is also working to make Cabotegravir, another highly effective injectable PrEP, locally available.
The Uganda AIDS Commission’s efforts demonstrate the country’s dedication to combting HIV/AIDS and promoting public health.
This development marks a significant milestone in Uganda’s fight against HIV/AIDS.
The introduction of Lenacapavir is expected to have a major impact on HIV prevention in the country.
It will provide individuals at high risk of HIV infection with a new and effective option for prevention.
The Uganda AIDS Commission and the Ministry of Health are working together to ensure that Lenacapavir is made available to those who need it.
This is a critical step towards achieving the goal of ending AIDS as a public health threat by 2030.
